These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26165647)

  • 1. Farnesoid X receptor knockdown provides significant growth inhibition in hepatocellular carcinoma cells while it does not interfere with the proliferation of primary human hepatocyte-derived cells.
    Fujino T; Maruko-Ohtake A; Ohtake Y; Kobayashi T; Ando K; Takeuchi A; Ohkubo Y; Hayakawa M
    J Toxicol Sci; 2015 Aug; 40(4):501-8. PubMed ID: 26165647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation.
    Fujino T; Takeuchi A; Maruko-Ohtake A; Ohtake Y; Satoh J; Kobayashi T; Tanaka T; Ito H; Sakamaki R; Kashimura R; Ando K; Nishimaki-Mogami T; Ohkubo Y; Kitamura N; Sato R; Kikugawa K; Hayakawa M
    J Biochem; 2012 Dec; 152(6):577-86. PubMed ID: 22969091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farnesoid X receptor regulates the growth of renal adenocarcinoma cells without affecting that of a normal renal cell-derived cell line.
    Fujino T; Sakamaki R; Ito H; Furusato Y; Sakamoto N; Oshima T; Hayakawa M
    J Toxicol Sci; 2017; 42(3):259-265. PubMed ID: 28496032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
    Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
    Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
    Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
    J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X induces cell proliferation in the hepatocarcinogenesis via up-regulation of cytoplasmic p21 expression.
    Yano M; Ohkoshi S; Aoki YH; Takahashi H; Kurita S; Yamazaki K; Suzuki K; Yamagiwa S; Sanpei A; Fujimaki S; Wakai T; Kudo SE; Matsuda Y; Aoyagi Y
    Liver Int; 2013 Sep; 33(8):1218-29. PubMed ID: 23590292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27.
    Kim JH; Choi YK; Byun JK; Kim MK; Kang YN; Kim SH; Lee S; Jang BK; Park KG
    Exp Mol Med; 2016 Mar; 48(3):e213. PubMed ID: 26940882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells.
    Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F
    Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
    Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
    Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells.
    Liu XC; Lian W; Zhang LJ; Feng XC; Gao Y; Li SX; Liu C; Cheng Y; Yang L; Wang XJ; Chen L; Wang RQ; Chai J; Chen WS
    PLoS One; 2015; 10(8):e0136215. PubMed ID: 26292095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
    Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
    Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of RhoC on hepatocellular carcinoma cell growth and related molecular mechanisms].
    Xie SL; Zhu MG; Lü GY; Wang GY
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):270-5. PubMed ID: 21575497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR induces SOCS3 and suppresses hepatocellular carcinoma.
    Guo F; Xu Z; Zhang Y; Jiang P; Huang G; Chen S; Lyu X; Zheng P; Zhao X; Zeng Y; Wang S; He F
    Oncotarget; 2015 Oct; 6(33):34606-16. PubMed ID: 26416445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of human lens epithelial cell proliferation by proteasome inhibition, a potential defense against posterior capsular opacification.
    Awasthi N; Wagner BJ
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4482-9. PubMed ID: 17003443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
    Martínez-Fernández P; Hierro L; Jara P; Alvarez L
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of curcumin on histone deacetylase and expression promotion of P21 (WAF1/CIP1) in HepG2 cells].
    Lv BH; Zhang L; Zhu CC; Liu J
    Zhongguo Zhong Yao Za Zhi; 2007 Oct; 32(19):2051-5. PubMed ID: 18161303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein].
    Mai L; Yang L; Kuang JY; Zhu JY; Kang YH; Zhang FC; Xie QF; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):614-8. PubMed ID: 24119743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.
    Cheng F; McLaughlin PJ; Verderame MF; Zagon IS
    Mol Biol Cell; 2009 Jan; 20(1):319-27. PubMed ID: 18923142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.